LawFuel.com – Personal Injury Attorney Law News – August 22, 2012
NEW YORK — Weiss & Lurie, a national class action and shareholder rights law firm with offices in New York City and Los Angeles, is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Sunrise Senior Living, Inc. (NYSE: SRZ) arising from its agreement for Sunrise to be acquired by Health Care REIT Inc. Under the terms of the agreement, Health Care REIT Inc. will acquire all of the outstanding common shares of Sunrise for $14.50 per share in cash.
Weiss & Lurie is investigating whether Sunrise’s Board acted in the best interests of its shareholders in approving this deal and whether Sunrise adequately shopped the Company to obtain the best price for Sunrise’s shareholders. Sunrise recently announced its second quarter results for 2012, reporting net income of $9.6 million or $0.16 per fully diluted share, as compared to net income of $1.3 million, or $0.2 per fully diluted share, for the second quarter of 2011. If you own Sunrise shares and would like more information about your rights as a shareholder or additional information concerning our investigation, please contact Michael A. Rogovin either by telephone at (888) 593-4771 or by email at firstname.lastname@example.org.
Weiss & Lurie has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded institutions and individuals and obtained important corporate governance in these cases. If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or issuing materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at email@example.com or fill out the form on our website, http://www.weisslurie.com/contact/report_fraud/.